Retinal deimination in aging and disease

IUBMB Life

Volumn 61, Issue 5, 2009, Pages 504-509

  Bhattacharya, Sanjoy K ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Ageing; Arginine metabolism; Complex diseases; Enzymology; Neurodegenerative disorders; Protein function; Proteomics

Indexed keywords

ARGININE; CITRULLINE; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE 2; UNCLASSIFIED DRUG; HYDROLASE; PROTEIN-ARGININE DEIMINASE;

AGING; ALLERGIC ENCEPHALOMYELITIS; DEGENERATIVE DISEASE; GLAUCOMA; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; PROTEIN PROCESSING; RETINA DEGENERATION; RETINA NERVE CELL; REVIEW; GENETICS; METABOLISM; RETINA DISEASE;

AGING; ARGININE; HUMANS; HYDROLASES; NEURODEGENERATIVE DISEASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINAL DISEASES;

EID: 67650388344     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.184     Document Type: Review

References (41)

1. Stadtman, E. R. (1988) Protein modification in aging. J. Gerontol. 43, B112-B120.
2. Vossenaar, E. R., Zendman, A. J., van Venrooij, W. J., and Pruijn, G. J. (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 25, 1106-1118.
3. Algeciras, M. E., and Bhattacharya, S. K. (2007) Targeting optic nerve citrullination in glaucoma: a role for protein-arginine deiminase 2 (PAD2) inhibitors. Drugs Future 32, 999-1006.
4. Bhattacharya, S. K., Crabb, J. S., Bonilha, V. L., Gu, X., Takahara, H., and Crabb, J. W. (2006) Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest. Ophthalmol. Vis. Sci. 47, 2508-2514.
5. Wood, D. D., Ackerley, C. A., Brand, B., Zhang, L., Raijmakers, R., Mastronardi, F. G., and Moscarello, M. A. (2008) Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities. Lab. Invest. 88, 354-364.
6. Grant, J. E., Hu, J., Liu, T., Jain, M. R., Elkabes, S., and Li, H. (2007) Post-translational modifications in the rat lumbar spinal cord in experimental autoimmune encephalomyelitis. J. Proteome. Res. 6, 2786-2791.
7. Holm, A., Rise, F., Sessler, N., Sollid, L. M., Undheim, K., and Fleckenstein, B. (2006) Specific modification of peptide-bound citrulline residues. Anal. Biochem. 352, 68-76.
8. Chavanas, S., Mechin, M. C., Nachat, R., Adoue, V., Coudane, F., Serre, G., and Simon, M. (2006) Peptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasis. J. Dermatol. Sci. 44, 63-72.
9. Mechin, M. C., Sebbag, M., Arnaud, J., Nachat, R., Foulquier, C., Adoue, V., Coudane, F., Duplan, H., Schmitt, A. M., Chavanas, S., Guerrin, M., Serre, G., and Simon, M. (2007) Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. Int. J. Cosmet. Sci. 29, 147-168.
10. Asaga, H., Yamada, M., and Senshu, T. (1998) Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem. Biophys. Res. Commun. 243, 641-646.
11. Iida, A., and Nakamura, Y. (2004) Identification of 45 novel SNPs in the 83-kb region containing peptidylarginine deiminase types 1 and 3 loci on chromosomal band 1p36.13. J. Hum. Genet. 49, 387-390.
12. Asaga, H., and Ishigami, A. (2001) Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration. Neurosci. Lett. 299, 5-8.
13. Wang, Y., Wysocka, J., Sayegh, J., Lee, Y. H., Perlin, J. R., Leonelli, L., Sonbuchner, L. S., McDonald, C. H., Cook, R. G., Dou, Y., Roeder, R. G., Clarke, S., Stallcup, M. R., Allis, C. D., and Coonrod, S. A. (2004) Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306, 279-283.
14. Cuthbert, G. L., Daujat, S., Snowden, A. W., Erdjument-Bromage, H., Hagiwara, T., Yamada, M., Schneider, R., Gregory, P. D., Tempst, P., Bannister, A. J., and Kouzarides, T. (2004) Histone deimination antagonizes arginine methylation. Cell 118, 545-553.
15. Raijmakers, R., Zendman, A. J., Egberts, W. V., Vossenaar, E. R., Raats, J., Soede-Huijbregts, C., Rutjes, F. P., van Veelen, P. A., Drijfhout, J. W., and Pruijn, G. J. (2007) Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J. Mol. Biol. 367, 1118-1129.
16. Thompson, P. R., and Fast, W. (2006) Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? ACS Chem. Biol. 1, 433-441.
17. Esposito, G., Vitale, A. M., Leijten, F. P., Strik, A. M., Koonen-Reemst, A. M., Yurttas, P., Robben, T. J., Coonrod, S., and Gossen, J. A. (2007) Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol. Cell. Endocrinol. 273, 25-31.
18. Watanabe, K., Akiyama, K., Hikichi, K., Ohtsuka, R., Okuyama, A., and Senshu, T. (1988) Combined biochemical and immunochemical comparison of peptidylarginine deiminases present in various tissues. Biochim. Biophys. Acta. 966, 375-383.
19. Boyde, T. R., and Rahmatullah, M. (1980) Optimization of conditions for the colorimetric determination of citrulline, using diacetyl monoxime. Anal. Biochem. 107, 424-431.
20. Liao, Y. F., Hsieh, H. C., Liu, G. Y., and Hung, H. C. (2005) A continuous spectrophotometric assay method for peptidylarginine deiminase type 4 activity. Anal. Biochem. 347, 176-181.
21. Senshu, T., Sato, T., Inoue, T., Akiyama, K., and Asaga, H. (1992) Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal. Biochem. 203, 94-100.
22. Nicholas, A. P., and Whitaker, J. N. (2002) Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain. Glia 37, 328-336.
23. Nicholas, A. P., Sambandam, T., Echols, J. D., and Barnum, S. R. (2005) Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis. J. Comp. Neurol. 486, 254-266.
24. Schoneich, C. (2006) Protein modification in aging: an update. Exp. Gerontol. 41, 807-812.
25. Bhattacharya, S. K., Sinicrope, B., Rayborn, M. E., Hollyfield, J. G., and Bonilha, V. L. (2008) Age-related reduction in retinal deimination levels in the F344BN rat. Aging. Cell. 7, 441-444.
26. Cheng, H., Nair, G., Walker, T. A., Kim, M. K., Pardue, M. T., Thule, P. M., Olson, D. E., and Duong, T. Q. (2006) Structural and functional MRI reveals multiple retinal layers. Proc. Natl. Acad. Sci. U S A 103, 17525-17530.
27. Barnstable, C. J., and Drager, U. C. (1984) Thy-1 antigen: a ganglion cell specific marker in rodent retina. Neuroscience 11, 847-855.
28. Okabe, S., Shiomura, Y., and Hirokawa, N. (1989) Immunocytochemical localization of microtubule-associated proteins 1A and 2 in the rat retina. Brain Res. 483, 335-346.
29. Cristofanilli, M., Thanos, S., Brosius, J., Kindler, S., and Tiedge, H. (2004) Neuronal MAP2 mRNA: species-dependent differential dendritic targeting competence. J. Mol. Biol. 341, 927-934.
30. Bhattacharya, S. K., Bhat, M. B., and Takahara, H. (2006) Modulation of peptidyl arginine deiminase 2 and implication for neurodegeneration. Curr. Eye. Res. 31, 1063-1071.
31. Wood, D. D., Bilbao, J. M., O'Connors, P., and Moscarello, M. A. (1996) Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein. Ann. Neurol. 40, 18-24.
32. Proost, P., Loos, T., Mortier, A., Schutyser, E., Gouwy, M., Noppen, S., Dillen, C., Ronsse, I., Conings, R., Struyf, S., Opdenakker, G., Maudgal, P. C., and Van Damme, J. (2008) Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J. Exp. Med. 205, 2085-2097.
33. Moscarello, M. A., Pritzker, L., Mastronardi, F. G., and Wood, D. D. (2002) Peptidylarginine deiminase: a candidate factor in demyelinating disease. J. Neurochem. 81, 335-343.
34. Nicholas, A. P., Sambandam, T., Echols, J. D., and Tourtellotte, W. W. (2004) Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J. Comp. Neurol. 473, 128-136.
35. Louw, C., Gordon, A., Johnston, N., Mollatt, C., Bradley, G., and Whiteley, C. G. (2007) Arginine deiminases: therapeutic tools in the etiology and pathogenesis of Alzheimer's disease. J. Enzyme. Inhib. Med. Chem. 22, 121-126.
36. Maruyama, N., Ishigami, A., and Kondo, Y. (2005) [Molecular abnormality in aging: its contribution to clinical pathology]. Rinsho. Byori. 53, 728-734.
37. Ishigami, A., Ohsawa, T., Hiratsuka, M., Taguchi, H., Kobayashi, S., Saito, Y., Murayama, S., Asaga, H., Toda, T., Kimura, N., and Maruyama, N. (2005) Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J. Neurosci. Res. 80, 120-128.
38. Chou, S. M., Wang, H. S., and Taniguchi, A. (1996) Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J Neurol. Sci. 139, (Suppl), 16-26.
39. Scofield, R. H. (2004) Autoantibodies as predictors of disease. Lancet 363, 1544-1546.
40. Kidd, B. A., Ho, P. P., Sharpe, O., Zhao, X., Tomooka, B. H., Kanter, J. L., Steinman, L., and Robinson, W. H. (2008) Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis. Res. Ther. 10, R119.
41. Jang, B., Kim, E., Choi, J. K., Jin, J. K., Kim, J. I., Ishigami, A., Maruyama, N., Carp, R. I., Kim, Y. S., and Choi, E. K. (2008) Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis. Am. J. Pathol. 173, 1129-1142.